Free alerts

RA Capital Healthcare Fund LP: insider buys

Every open-market stock purchase reported by RA Capital Healthcare Fund LP to the SEC on Form 4.

Total bought$63.83M
Purchases6
Companies5
Last purchase filedJul 31, 2026
Return on these buys-20%

RA Capital Healthcare Fund LP has made 6 open-market purchases worth $63.83M in 5 companies since Jan 7, 2026, according to SEC Form 4 filings. The most recent was filed on Jul 31, 2026: 45,768 shares of ARTV at $9.96 (Director, 10% Owner), worth $455.73K. The largest was $59.04M of SGP on Feb 9, 2026. Taken together, these purchases are down 20% at the latest closing prices (split-adjusted, weighted by amount).

Companies RA Capital Healthcare Fund LP bought

TickerCompanyRoleBuysTotalSince buyLast filed
SGPSpyGlass Pharma, Inc.Director, 10% Owner1$59.04M—Feb 11
ARTVArtiva Biotherapeutics, Inc.Director, 10% Owner2$1.89M-54%Jul 31
ACETAdicet Bio, Inc.10% Owner1$1.60M-52%Apr 13
COAGHemab Therapeutics Holdings, Inc.10% Owner1$1.27M+67%May 11
CLYMClimb Bio, Inc.Director, 10% Owner1$24.89K+193%Jan 7

Get the next RA Capital Healthcare Fund LP purchase on TelegramFree daily recap of the biggest insider purchases, straight from SEC filings. Real-time alerts for Premium members.

Join free on Telegram

All purchases

FiledStockInsiderValueSharesPriceSince buyStakeTrade
Jul 31ARTVArtiva Biotherapeutics, Inc.RA Capital Healthcare Fund LP…Director, 10% Owner$455.73K45,768$9.96-58%+0%Jul 29SEC
Jul 20ARTVArtiva Biotherapeutics, Inc.RA Capital Healthcare Fund LP…Director, 10% Owner$1.43M160,354$8.93-53%+1%Jul 16SEC
May 11COAGHemab Therapeutics Holdings…RA Capital Healthcare Fund LP…10% Owner$1.27M51,258$24.75+67%+1%May 7SEC
Apr 13ACETAdicet Bio, Inc.RA Capital Healthcare Fund LP…10% Owner$1.60M223,596$7.17-52%+23%Feb 18SEC
Feb 11SGPSpyGlass Pharma, Inc.RA Capital Healthcare Fund LP…Director, 10% Owner$59.04M3,690,000$16.00—+162%Feb 9SEC
Jan 7CLYMClimb Bio, Inc.RA Capital Healthcare Fund LP…Director, 10% Owner$24.89K7,111$3.50+193%+0%Jan 5SEC